Frederic Sallmann is an accomplished entrepreneur and board member with over 15 years of global experience in the healthcare industry, ranging from startup ventures to multinational corporations. They have held significant roles such as Head of Innovation at Glaxosmithkline vaccines and currently serve as CEO at Railroad Therapeutics, where they focus on generative AI drug design. Frederic co-founded SCieNSATiON, which aims to help organizations navigate their challenges, and is a board observer at Antleron, dedicated to advancing regenerative medicine. Their academic credentials include multiple degrees, such as a Ph.D. from Université Laval and certifications from prestigious institutions like MIT and Vlerick Business School.
This person is not in the org chart
This person is not in any teams
This person is not in any offices